In 2023, West Pharmaceutical Services completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, West Pharmaceutical Services has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of West Pharmaceutical Services amounted to 104,190 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of West Pharmaceutical Services decreased by 15.25%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
In 2023, the total Scope 1 emissions of West Pharmaceutical Services were 30,828 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Since 2018, West Pharmaceutical Services's Scope 1 emissions have increased by 2.6%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), West Pharmaceutical Services's Scope 1 emissions decreased by 1.73%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
In 2023, West Pharmaceutical Services reported Scope 2 greenhouse gas (GHG) emissions of 73,362 tCOâ‚‚e without specifying the calculation method.
Since 2018, West Pharmaceutical Services's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 32.88%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), West Pharmaceutical Services's Scope 2 emissions (Unspecified Calculation Method) fell by 19.88% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
In 2023, West Pharmaceutical Services reported its Scope 2 emissions using an unspecified methodology.